Abstract
The determination of stanozolol and its metabolites in human urine has been of particular interest in sports drug testing due to its frequently revealed misuse. A simple and rapid sample preparation procedure based on consecutive solid-phase and liquid–liquid extraction with subsequent re-extraction followed by liquid chromatography and electrospray ionization tandem mass spectrometry was established. It allowed the determination of stanozolol and its metabolic products 16β-OH-stanozolol and 4β-OH-stanozolol in human urine at detection limits of 0.1, 0.2 and 0.2 ng mL−1, respectively, with recoveries ranging from 5 to 38%. The robust nature of the assay and the efficient removal of interfering biological matrix provides excellent signal-to-noise ratios, and, thus, a rapid alternative to established procedures utilizing multiple solid-phase extraction or immunoaffinity chromatography strategies. More than 15 doping control urine specimens tested positive for stanozolol during the last 12 months have been confirmed using the described approach.
References
Clinton RO, Manson AJ, Stonner FW, Neumann HC, Christiansen RG, Clarke RL, Ackerman JH, Page DF, Dean JW, Dickinson WB, Carabateas C (1961) J Am Chem Soc 83:1478–1491
Camerino B, Sciaky R (1975) Pharmac Therap B 1:233–275
Schänzer W, Opfermann G, Donike M (1990) J Steroid Biochem 36:153–174
Schänzer W, Delahaut P, Geyer H, Machnik M, Horning S (1996) J Chromatogr B 687:93–108
Masse R, Ayotte C, Bi HG, Dugal R (1989) J Chromatogr 497:17–37
McKinney AR, Suann CJ, Dunstan AJ, Mulley SL, Ridley DD, Stenhouse AM (2004) J Chromatogr B 811:75–83
Mück WM, Henion JD (1990) Biomed Environ Mass Spectrom 19:37–51
Poelmans S, De Wasch K, De Brabander HF, Van de Wiele M, Courtheyn D, van Ginkel LA, Sterk SS, Delahaut P, Dubois M, Schilt R, Nielen M, Vercammen J, Impens S, Stephany R, Hamoir T, Pottie G, Van Poucke C, Van Peteghem C (2002) Anal Chim Acta 473:39–47
Schänzer W (1996) Clin Chem 42:1001–1020
Kicman AT, Gower DB (2003) Ann Clin Biochem 40:321–356
uMarcos J, Pascual JA, de la Torre X, Segura J (2002) J Mass Spectrom 37:1059–1073
ICH (2004) In: International Conference on Harmonisation, vol 2004
Dams R, Huestis MA, Lambert WE, Murphy CM (2003) J Am Soc Mass Spectrom 14:1290–1294
Thevis M, Makarov AA, Horning S, Schänzer W (2005) Rapid Commun Mass Spectrom 19:3369–3378
Horning S, Donike M (1994) In: Donike M, Geyer H, Gotzmann A, Mareck-Engelke U, Rauth S (eds) Recent advances in doping analysis. Sport&Buch Strauß, Cologne, pp 155–161
Van de Wiele M, De Wasch K, Vercammen J, Courtheyn D, De Brabanter H, Impens S (2000) J Chromatogr A 904:203–209
Acknowledgments
The authors thank the Manfred-Donike Gesellschaft, Cologne, for support. This project was carried out with support of the International Bureau of the Federal Ministry of Education and Research, Bonn, and the Manfred-Donike Gesellschaft, Cologne.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Thevis, M., Fußhöller, G., Geyer, H. et al. Detection of Stanozolol and Its Major Metabolites in Human Urine by Liquid Chromatography-Tandem Mass Spectrometry. Chroma 64, 441–446 (2006). https://doi.org/10.1365/s10337-006-0043-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1365/s10337-006-0043-3